Meloxicam
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
Common Name | Meloxicam(F05809) |
2D Structure | |
FRCD ID | F05809 |
CAS Number | 71125-38-7 |
PubChem CID | 54677470 |
Formula | C14H13N3O4S2 |
IUPAC Name | 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1$l^{6},2-benzothiazine-3-carboxamide |
InChI Key | ZRVUJXDFFKFLMG-UHFFFAOYSA-N |
InChI | InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19) |
Canonical SMILES | CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O |
Isomeric SMILES | CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O |
Synonyms | Mobec meloxicam 71125-38-7 Mobic Metacam Movalis Mobicox Meloxicam (Mobic) Meloxicamum Movatec |
Classifies | Predicted: Plant Toxin |
Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
Kingdom | Organic compounds |
Superclass | Organoheterocyclic compounds |
Class | Benzothiazines |
Subclass | Not available |
Intermediate Tree Nodes | Not available |
Direct Parent | Benzothiazines |
Alternative Parents | |
Molecular Framework | Aromatic heteropolycyclic compounds |
Substituents | Alpha-amino acid or derivatives - Benzothiazine - N-arylamide - 2,5-disubstituted 1,3-thiazole - Ortho-thiazine - Benzenoid - Organosulfonic acid amide - Azole - Heteroaromatic compound - Vinylogous acid - Thiazole - Organosulfonic acid or derivatives - Organic sulfonic acid or derivatives - Carboxamide group - Secondary carboxylic acid amide - Azacycle - Carboxylic acid derivative - Organic oxygen compound - Organic nitrogen compound - Carbonyl group - Hydrocarbon derivative - Organic oxide - Organopnictogen compound - Organonitrogen compound - Organooxygen compound - Aromatic heteropolycyclic compound |
Description | This compound belongs to the class of organic compounds known as benzothiazines. These are organic compounds containing a benzene fused to a thiazine ring (a six-membered ring with four carbon atoms, one nitrogen atom and one sulfur atom). |
Properties
Property Name | Property Value |
---|---|
Molecular Weight | 351.395 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 2 |
Complexity | 628 |
Monoisotopic Mass | 351.035 |
Exact Mass | 351.035 |
XLogP | 3 |
Formal Charge | 0 |
Heavy Atom Count | 23 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
ADMET
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB- | 0.9811 |
Human Intestinal Absorption | HIA+ | 0.9156 |
Caco-2 Permeability | Caco2+ | 0.8484 |
P-glycoprotein Substrate | Substrate | 0.5181 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7516 |
Non-inhibitor | 0.7491 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.9275 |
Distribution | ||
Subcellular localization | Mitochondria | 0.4348 |
Metabolism | ||
CYP450 2C9 Substrate | Substrate | 0.5637 |
CYP450 2D6 Substrate | Non-substrate | 0.9117 |
CYP450 3A4 Substrate | Non-substrate | 0.6649 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9271 |
CYP450 2C9 Inhibitor | Inhibitor | 0.5511 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9322 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8948 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8191 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7316 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9579 |
Non-inhibitor | 0.7999 | |
AMES Toxicity | Non AMES toxic | 0.8576 |
Carcinogens | Non-carcinogens | 0.7052 |
Fish Toxicity | High FHMT | 0.8811 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9476 |
Honey Bee Toxicity | Low HBT | 0.7855 |
Biodegradation | Not ready biodegradable | 0.9312 |
Acute Oral Toxicity | II | 0.6971 |
Carcinogenicity (Three-class) | Non-required | 0.6941 |
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -3.7597 | LogS |
Caco-2 Permeability | 1.2073 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 3.4619 | LD50, mol/kg |
Fish Toxicity | 1.6914 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.5386 | pIGC50, ug/L |
MRLs
Food | Product Code | Country | MRLs | Application Date | Notes |
---|---|---|---|---|---|
Milk | Japan | 0.01ppm | |||
Other Terrestrial Mammals,Edible Offal | Japan | 0.07ppm | |||
Pig,Edible Offal | Japan | 0.06ppm | |||
Cattle,Edible Offal | Japan | 0.07ppm | |||
Other Terrestrial Mammals,Kidney | Japan | 0.07ppm | |||
Pig,Kidney | Japan | 0.09ppm | |||
Cattle,Kidney | Japan | 0.1ppm | |||
Other Terrestrial Mammals,Liver | Japan | 0.07ppm | |||
Pig,Liver | Japan | 0.06ppm | |||
Cattle,Liver | Japan | 0.07ppm | |||
Other Terrestrial Mammals,Fat | Japan | 0.02ppm | |||
Pig,Fat | Japan | 0.1ppm | |||
Pig,Muscle | Japan | 0.02ppm | |||
Cattle,Muscle | Japan | 0.02ppm | |||
Cattle,Fat | Japan | 0.02ppm | |||
Other Terrestrial Mammals,Muscle | Japan | 0.02ppm |
References
Title | Journal | Date | Pubmed ID |
---|---|---|---|
Changes in feeding, social, and lying behaviors in dairy cows with metritisfollowing treatment with a nonsteroidal anti-inflammatory drug as adjunctivetreatment to an antimicrobial. | J Dairy Sci | 2018 May | 29477521 |
Gastroscopic Study of Meloxicam, Tramadol, and Their Combined Administration onthe Development of Gastric Injuries in Dogs. | Top Companion Anim Med | 2017 Sep | 29291772 |
Evaluation of in-feed larch sawdust anti-inflammatory effect in sows. | Pol J Vet Sci | 2017 Mar 1 | 28865211 |
Clinical trial of local anesthetic protocols for acute pain associated withcaustic paste disbudding in dairy calves. | J Dairy Sci | 2017 Aug | 28551190 |
YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuatesneurodegenerative changes induced by β-amyloid (1-42) or double transgenicoverexpression of APP and PS1 via inhibition of cyclooxygenase-2. | J Neuroinflammation | 2017 Apr 27 | 28449688 |
Evaluation of meloxicam for the treatment of obstructive feline idiopathiccystitis. | J Feline Med Surg | 2016 Nov | 26672127 |
Addition of meloxicam to the treatment of clinical mastitis improves subsequentreproductive performance. | J Dairy Sci | 2016 Mar | 26778316 |
Hot topic: Early postpartum treatment of commercial dairy cows with nonsteroidal antiinflammatory drugs increases whole-lactation milk yield. | J Dairy Sci | 2016 Jan | 26519977 |
Meloxicam inhibits fipronil-induced apoptosis via modulation of the oxidativestress and inflammatory response in SH-SY5Y cells. | J Appl Toxicol | 2016 Jan | 25772694 |
Experimental study on the effect of oral meloxicam administration in sows onpre-weaning mortality and growth and immunoglobulin G transfer to piglets. | Prev Vet Med | 2016 Apr 1 | 26874363 |
Development of Analytical Method and Monitoring of Veterinary Drug Residues inKorean Animal Products. | Korean J Food Sci Anim Resour | 2016 | 27433102 |
A multiresidue liquid chromatographic/tandem mass spectrometric method for thedetection and quantitation of 15 nonsteroidal anti-inflammatory drugs (NSAIDs) inbovine meat and milk. | Anal Bioanal Chem | 2015 Jun | 25814273 |
Toxic influence. | Nature | 2014 Oct 23 | 25341753 |
Comparison of meloxicam and a glucosamine-chondroitin supplement in management offeline osteoarthritis. A double-blind randomised, placebo-controlled, prospectivetrial. | Vet Comp Orthop Traumatol | 2014 | 24146058 |
Hemodynamic and behavioral differences after administration of meloxicam,buprenorphine, or tramadol as analgesics for telemeter implantation in mice. | J Am Assoc Lab Anim Sci | 2013 Sep | 24041211 |
Effects of meloxicam on milk production, behavior, and feed intake in dairy cows following assisted calving. | J Dairy Sci | 2013 Jun | 23567050 |
Pharmacokinetics and milk secretion of gabapentin and meloxicam co-administeredorally in Holstein-Friesian cows. | J Vet Pharmacol Ther | 2013 Feb | 22372845 |
Aspirin augments IgE-mediated histamine release from human peripheral basophilsvia Syk kinase activation. | Allergol Int | 2013 Dec | 24153330 |
Target animal safety study of meloxicam administered via transmucosal oral spray (Promist(®) technology) for 6 months in dogs. | J Vet Pharmacol Ther | 2013 Aug | 23009183 |
Effects of buprenorphine and meloxicam analgesia on induced cerebral ischemia in C57BL/6 male mice. | Comp Med | 2013 Apr | 23582417 |